Conmed (CNMD) Treasury Shares (2010 - 2026)

Conmed has reported Treasury Shares for 17 years, with the latest figure at $49.0 million in Q1 2026.

• For the quarter ending Q1 2026, Treasury Shares rose 237.98% year-over-year to $49.0 million; the trailing twelve-month figure through Mar 2026 stood at $49.0 million (up 237.98% YoY), and the FY2025 full-year result was $12.9 million, down 17.53% from the prior year.
• Treasury Shares for Q1 2026 stood at $49.0 million, up from $12.9 million in the prior quarter.
• The five-year high for Treasury Shares was $1.8 million in Q1 2022, with the low at $46000.0 in Q4 2022.
• Historically, Treasury Shares has averaged $585810.0 across 5 years, with a median of $508028.0 in 2024.
• Annual changes were most pronounced in 2022 — Treasury Shares slumped 60.86% — and 2026, when it jumped 237.98%.
• Conmed's Treasury Shares stood at $22.8 million in 2022, then plunged by 34.2% to $15.0 million in 2023, then increased by 4.27% to $15.6 million in 2024, then retreated by 17.53% to $12.9 million in 2025, then soared by 280.55% to $49.0 million in 2026.
• The last three Treasury Shares figures came in at $49.0 million (Q1 2026), $12.9 million (Q4 2025), and $13.5 million (Q3 2025), per Business Quant data.